| ADALIMUMAB |
Humira® |
AbbVie Pty Ltd |
Moderate to severe hidradenitis suppurativa |
Nov 2019 |
|
| ALECTINIB AND CRIZOTINIB |
|
Medical Oncology Group of Australia |
Stage IIIB (locally advanced) or Stage IV (metastatic) nonsmall cell lung cancer (NSCLC) |
Nov 2019 |
|
| AMINO ACID FORMULA WITH FAT, CARBOHYDRATE WITHOUT METHIONINE |
HCU Easy® |
Orpharma Pty Ltd |
Pyridoxine non-responsive homocystinuria |
Nov 2019 |
|
| AMINO ACID FORMULA WITH FAT, CARBOHYDRATE WITHOUT PHENYLALANINE |
PKU Easy® |
Orpharma Pty Ltd |
Phenylketonuria (PKU) |
Nov 2019 |
|
| AMINO ACID FORMULA WITH FAT, CARBOHYDRATE WITHOUT PHENYLALANINE AND TYROSINE |
TYR Easy® |
Orpharma Pty Ltd |
Tyrosinaemia |
Nov 2019 |
|
| AMINO ACID FORMULA WITH FAT, CARBOHYDRATE WITHOUT VALINE, LEUCINE AND ISOLEUCINE |
MSUD Easy® |
Orpharma Pty Ltd |
Maple syrup urine disease |
Nov 2019 |
|
| AMINO ACID FORMULA WITH VITAMINS WITH MINERALS, WITHOUT VALINE, LEUCINE AND ISOLEUCINE
WITH DOCOSOHEXAENOIC ACID AND ARACHIDONIC ACID |
MSUD explore® |
Vitaflo Australia Pty Limited |
Maple syrup urine disease |
Nov 2019 |
|
| ATEZOLIZUMAB |
Tecentriq® 840mg in 14mL |
Roche Products Pty Ltd |
Non-small cell lung cancer (NSCLC) |
Nov 2019 |
|
| ATEZOLIZUMAB |
Tecentriq® 1200mg in 20mL |
Roche Products Pty Ltd |
Small cell lung cancer (SCLC) |
Nov 2019 |
|
| AUTHORISED NURSE PRACTITIONER PRESCRIBING FOR HEPATITIS B, HEPATITIS C AND HUMAN IMMUNODEFICIENCY
VIRUS MEDICINES UNDER THE HIGHLY SPECIALISED DRUGS (HSD) PROGRAM |
|
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine |
Hepatitis B; Hepatitis C; and Human Immunodeficiency Virus |
Nov 2019 |
|
| BELIMUMAB |
Benlysta® |
GlaxoSmithKline Australia Pty Ltd |
Systemic lupus erythematosus (SLE) |
Nov 2019 |
|
| BOTULINUM TOXIN TYPE A PURIFIED NEUROTOXIN COMPLEX |
Botox® |
Allergan Australia Pty Ltd |
Spasticity of the upper limb |
Nov 2019 |
|
| BRIGATINIB |
Alunbrig® |
Takeda Pharmaceuticals Australia Pty. Ltd. |
Non-small cell lung cancer (NSCLC) |
Nov 2019 |
|
| BRIVARACETAM |
Briviact® |
UCB Australia Proprietary Limited |
Epilepsy |
Nov 2019 |
|
| BROLUCIZUMAB |
Beovu® |
Novartis Pharmaceuticals Australia Pty Limited |
Subfoveal choroidal neovascularisation (CNV) |
Nov 2019 |
|
| BUDESONIDE WITH FORMOTEROL |
Symbicort Turbuhaler® |
AstraZeneca Pty Ltd |
Asthma |
Nov 2019 |
|
| BUPRENORPHINE |
Sublocade® |
Indivior Pty Ltd |
Opiate dependence |
Nov 2019 |
|
| BUPRENORPHINE WITH NALOXONE |
Zubsolv® |
Mundipharma Pty Limited |
Opiate dependence |
Nov 2019 |
|
| CERTOLIZUMAB PEGOL |
Cimzia® |
UCB Australia Pty Ltd |
Chronic plaque psoriasis (CPP) |
Nov 2019 |
|
| CERTOLIZUMAB PEGOL |
Cimzia® |
UCB Australia Pty Ltd |
Non-radiographic axial sponyloarthritis (nr-axSpA) |
Nov 2019 |
|
| DARATUMUMAB |
Darzalex® |
Janssen-Cilag Pty Ltd |
Multiple myeloma |
Nov 2019 |
|
| DARUNAVIR WITH COBICISTAT WITH EMTRICITABINE AND TENOFOVIR ALAFENAMIDE |
Symtuza® |
Janssen-Cilag Pty Ltd |
Human immunodeficiency virus (HIV) infection |
Nov 2019 |
|
| DIMETHYL FUMARATE |
Tecfidera® |
Biogen Australia Pty Ltd |
Relapsing-remitting multiple sclerosis (RRMS) |
Nov 2019 |
|
| DULAGLUTIDE |
Trulicity® |
Eli Lilly Australia Pty Ltd |
Type 2 diabetes mellitus (T2DM) |
Nov 2019 |
|
| DURVALUMAB |
Imfinzi® |
AstraZeneca Pty Ltd |
Non-small cell lung cancer (NSCLC) |
Nov 2019 |
|
| EVOLOCUMAB |
Repatha® |
Amgen Australia Pty Limited |
Hypercholesterolaemia |
Nov 2019 |
|
| FREMANEZUMAB |
Ajovy® |
Teva Pharma Australia Pty Ltd |
Chronic migraine |
Nov 2019 |
|
| GLYCOMACROPEPTIDE AND ESSENTIAL AMINO ACIDS WITH VITAMINS AND MINERALS |
- PKU Build 10®
- PKU Build 20®
|
Cortex Health Pty Ltd |
Phenylketonuria |
Nov 2019 |
|
| HIGH DOSE INACTIVATED TRIVALENT INFLUENZA VACCINE (SPLIT VIRION) |
Fluzone® High-Dose |
Sanofi–Aventis Australia Pty Ltd |
Influenza |
Nov 2019 |
|
| IBRUTINIB |
Imbruvica® |
Janssen-Cilag Pty Ltd |
Chronic lymphocytic leukaemia (CLL); small lymphocytic lymphoma (SLL) |
Nov 2019 |
|
| INACTIVATED QUADRIVALENT INFLUENZA VACCINE (SPLIT VIRION) |
FluQuadri™ |
Sanofi-Aventis Australia Pty Ltd |
Influenza |
Nov 2019 |
|
| INCOBOTULINUMTOXIN A |
Xeomin® |
Merz Australia Pty Ltd |
Spasticity of the upper limb |
Nov 2019 |
|
| ISOTRETINOIN |
Oratane® |
Oraderm Pharmaceuticals Pty Ltd |
Severe cystic acne |
Nov 2019 |
|
| LEVODOPA WITH CARBIDOPA |
Duodopa® |
AbbVie Pty Ltd |
Parkinson disease |
Nov 2019 |
|
| LORLATINIB |
Lorviqua® |
Pfizer Australia Pty Ltd |
Non-small cell lung cancer (NSCLC) |
Nov 2019 |
|
| MULTICOMPONENT MENINGOCOCCAL GROUP B VACCINE |
Bexsero® |
GlaxoSmithKline Australia Pty Ltd |
Meningococcal disease |
Nov 2019 |
|
| NERATINIB |
Nerlynx® |
Specialised Therapeutics Australia Pty Ltd |
Early breast cancer |
Nov 2019 |
|
| NIVOLUMAB |
Opdivo® |
Bristol-Myers Squibb Australia Pty Ltd |
Melanoma |
Nov 2019 |
|
| NIVOLUMAB; IPILIMUMAB |
|
Bristol-Myers Squibb Australia Pty Ltd |
Melanoma |
Nov 2019 |
|
| NUSINERSEN |
Spinraza® |
Biogen Australia Pty Ltd |
Spinal muscular atrophy |
Nov 2019 |
|
| OLAPARIB |
Lynparza® |
AstraZeneca Pty Ltd |
Ovarian, fallopian tube or primary peritoneal cancer |
Nov 2019 |
|
| PATIROMER |
Veltassa® |
Vifor Pharma Pty Limited |
Hyperkalaemia |
Nov 2019 |
|
| PEGFILGRASTIM |
Ziextenzo® |
Sandoz Pty Ltd |
Chemotherapy-induced neutropenia |
Nov 2019 |
|
| PEMBROLIZUMAB |
Keytruda® |
Merck Sharp & Dohme (Australia) Pty Ltd |
Melanoma |
Nov 2019 |
|
| POLATUZUMAB VEDOTIN |
Polivy® |
Roche Products Pty Ltd |
Diffuse large B-cell lymphoma (DLBCL) |
Nov 2019 |
|
| POMALIDOMIDE |
Pomalyst® |
Celgene Pty Limited |
Multiple myeloma |
Nov 2019 |
|
| PREDNISOLONE ACETATE WITH PHENYLEPHRINE |
Prednefrin® Forte |
National Aboriginal Community Controlled Health Organisation |
Severe inflammation of the eye |
Nov 2019 |
|
| PRIMIDONE |
APO Primidone® |
|
Epilepsy |
Nov 2019 |
|
| PROTEIN FORMULA WITH VITAMINS AND MINERALS, AND LOW IN POTASSIUM, PHOSPHORUS, CALCIUM,
CHLORIDE AND VITAMIN A |
Renastep® |
Vitaflo Australia Pty Limited |
Chronic kidney disease (CKD) |
Nov 2019 |
|
| RUXOLITINIB |
Jakavi® |
Novartis Pharmaceuticals Australia Pty Limited |
Polycythemia vera (PV) |
Nov 2019 |
|
| SALBUTAMOL |
Ventolin® |
GlaxoSmithKline Australia Pty Ltd |
Asthma; Chronic obstructive pulmonary disease (COPD) |
Nov 2019 |
|
| SEMAGLUTIDE |
Ozempic® |
Novo Nordisk Pharmaceuticals Pty. Limited |
Type 2 diabetes mellitus (T2DM) |
Nov 2019 |
|
| SIPONIMOD |
Mayzent® |
Novartis Pharmaceuticals Australia Pty Limited |
Secondary progressive multiple sclerosis (SPMS) |
Nov 2019 |
|
| TACROLIMUS |
Advagraf XL® |
Astellas Pharma Australia Pty Ltd |
Management of rejection in patients following organ or tissue transplantation |
Nov 2019 |
|
| TALAZOPARIB |
Talzenna® |
Pfizer Australia Pty Ltd |
Advanced breast cancer |
Nov 2019 |
|
| TEZACAFTOR WITH IVACAFTOR |
Symdeko® |
Vertex Pharmaceuticals (Australia) Pty. Ltd. |
Cystic Fibrosis (CF) |
Nov 2019 |
|
| TOLVAPTAN |
Jinarc® |
Otsuka Australia Pharmaceutical Pty. Ltd |
Autosomal dominant polycystic kidney disease (ADPKD) |
Nov 2019 |
|
| TRASTUZUMAB |
Trazimera® |
Pfizer Australia Pty Ltd |
Breast cancer; Gastric cancer |
Nov 2019 |
|
| TRASTUZUMAB EMTANSINE |
Kadcyla® |
Roche Products Pty Ltd |
Early breast cancer |
Nov 2019 |
|
| TRIFLURIDINE WITH TIPIRACIL |
Lonsurf® |
Servier Laboratories (Aust.) Pty. Ltd. |
Gastric cancer |
Nov 2019 |
|
| UPADACITINIB |
Rinvoq® |
AbbVie Pty Ltd |
Rheumatoid arthritis (RA) |
Nov 2019 |
|